Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis infection that is resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs. It poses a significant public health challenge due to its complex treatment regimen and higher mortality rates compared to drug-susceptible TB.